脑栓通胶囊对脑梗死的治疗及预防作用  

The Therapy and Prevention of Naoshuantong Capsule for Cerebral Infarction

作　　者：刘建祥[1] 李兴明[1] 

机构地区：[1]汕头大学医学院附属粤北人民医院神经内科,广东韶关512026

出　　处：《中国医药指南》2012年第18期5-6,共2页Guide of China Medicine

摘　　要：目的探讨脑栓通胶囊对脑梗死的治疗及预防作用。方法 173例脑梗死患者分为脑栓通治疗组87例,非脑栓通治疗组86例,观察2组患者脑梗死后90d的神经功能恢复情况,比较2组患1年内脑梗死的复发情况。结果 90d后脑梗死患者的NIHSS神经功能缺损评分、Barthel指数,2组患者的评分值有明显差异,脑栓通治疗组优于非脑栓通治疗组。1年内脑栓通治疗组的复发率为11.3%,非脑栓通治疗组的复发率为26.7%,2组有明显差异。结论脑栓通胶囊能改善脑梗死患者的预后,并能降低初次脑梗死后1年内的发病风险。Objective To investigate the effect of traditional Chinese medicine, Naoshuantong capsule on the therapy and prevention of the cerebral infarction. Method 173 patients were divided into two groups randomly, which included treatment group and control group, to evaluate the functional recovery of nerve after the 90 days treatment. Results There was statistically significant difference between the two groups in the functional scores of nerve defect （NIHSS and Barthel index）. One-year recurrence rate in intervention group was 11.3%, in control group was 26.7%（P〈0.05）. Conclusion The prognosis of the cerebral infarction patients was elevated on the treatment of the Naoshuantong capsule, and the morbidity risk of the incidence of one-year was decreased.

关 键 词：脑栓通胶囊 脑梗死 NIHSS神经功能缺损评分 BARTHEL指数 脑梗死的复发率 

分 类 号：R743.3[医药卫生—神经病学与精神病学]